Search
Quest Diagnostics Inc
DGXAdd to Watchlist
238.930USD
+1.810+0.76%
Close 10-21 16:00（ET）
26.37BMarket Cap
25.93P/E TTM
Pre-market 07:15 (ET)235.000USD-3.930-1.65%
Pre-market 07:15 (ET)Quest Diagnostics Inc (DGX) Stock Price Target & Forecast
Analyst Rating
Based on 19 analysts giving stock ratings to Quest Diagnostics Inc in the past month.
Buy
5 Strong Buy
5 Buy
9 Hold
0 Sell
0 Strong Sell
Target Price
246.023USD+4.69%
DGX Analyst Recommendation Trends
In the current month, DGX has received 5 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. DGX average Analyst price target in the last month is 246.023.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
9
9
9
9
9
10
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
19
19
19
19
20
20
20
DGX Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
3
0
0
28
HCA Healthcare Inc
HCA
5
10
11
1
0
27
Tenet Healthcare Corp
THC
5
15
4
0
0
24
Natera Inc
NTRA
10
12
2
0
0
24
Teladoc Health Inc
TDOC
2
3
18
0
0
23
Universal Health Services Inc
UHS
2
4
14
1
0
21
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Labcorp Holdings Inc
LH
6
8
5
0
0
19
Privia Health Group Inc
PRVA
5
12
1
0
0
18
Hims & Hers Health Inc
HIMS
0
4
12
0
0
16
Financial Forecasting
Based on analysts' estimates, DGX EPS is projected to reach 2.862 in FY2026Q3, following reported EPS of 2.874 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.36
2.35
2.83
2.86
2.68
Actual
8.90
2.28
2.87
--
--
Surprise
+277.11%
-2.71%
+1.72%
--
--
FAQs
What is Quest Diagnostics Inc's expected revenue for the next quarter?
Quest Diagnostics Inc's expected revenue is 3.04B.
What is Quest Diagnostics Inc's price target?
Analysts forecast that Quest Diagnostics Inc's price target is USD 246.36, with the highest forecast at USD 265.00 and the lowest forecast at USD 208.34.
How have Quest Diagnostics IncDGX's recent earnings per share performed?
The market expectation was USD 2.87, while Quest Diagnostics IncDGX's earnings per share (EPS) for the previous quarter was USD 2.28. EPS for the next quarter is expected at USD 2.86.
What is the analyst rating for Quest Diagnostics Inc?
Based on the ratings of Quest Diagnostics Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.